World News: 21:01 GMT Thursday 3rd January 2019. [Reata Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
IRVING Texas Jan 03 2019 GLOBE NEWSWIRE -- Reata Pharmaceuticals Inc (Nasdaq: RETA a clinical-stage biopharmaceutical company today announced that it has completed a successful end-of-Phase 2 meeting with the United States Food and Drug Admini...
Globe Newswire: 21:01 GMT Thursday 3rd January 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.